Optimization of Immunohistochemistry Workflow for Progesterone Receptor Antibody Reagents and Analysis of Common Pitfalls

Selection and Impact of Antigen Retrieval Conditions

In the detection workflow of progesterone receptor antibody reagent (immunohistochemistry), antigen retrieval is a critical step that determines staining success. The commonly used retrieval solutions are citrate buffer at pH 6.0 or EDTA buffer at pH 9.0; the latter provides better exposure of nuclear antigens but may increase background signal. Laboratories should determine the optimal retrieval temperature (generally recommended 95–100°C) and time (typically 15–30 minutes) through preliminary experiments based on their own tissue processing conditions. Insufficient retrieval easily leads to false negatives, while excessive retrieval may destroy antigen epitopes and similarly affect interpretation. Retrieval parameters must be documented in detail in experimental reports to ensure batch-to-batch consistency.

Optimization of Antibody Dilution and Incubation Parameters

Concentrated progesterone receptor antibody reagent needs to be prepared with antibody diluent at the recommended ratio. It is advisable to perform gradient dilution tests (e.g., 1:50, 1:100, 1:200, etc.) before first use to determine the concentration that achieves the optimal signal-to-noise ratio. Incubation temperature and time also need to be controlled: room temperature incubation is generally 30–60 minutes, while overnight incubation at 4°C can enhance signal but requires attention to avoid nonspecific binding. For automated immunohistochemistry platforms, reagent parameters need to be entered into the system and calibrated regularly. Any claims of "absolute accuracy" or "no background" constitute inappropriate advertising and should only be described as "low background or acceptable nonspecific staining."

Specifications for Setting Up Positive and Negative Controls

Each detection must include a known PR-positive tissue section (e.g., breast cancer tissue) and a negative control (e.g., normal liver tissue or isotype control). The positive control should show the expected degree of nuclear staining, and the negative control should not exhibit obvious positive signal. If control results do not meet expectations, the batch should be considered invalid, and the cause should be investigated (e.g., antibody failure, incorrect retrieval solution, detection system malfunction, etc.). Control images should be retained in records for traceability. In reagent promotion, it is acceptable to mention "assisting users in establishing quality control systems," but it must not be claimed to "eliminate errors."

Common Misconceptions and Improvement Recommendations

Misconception one: Ignoring the impact of tissue fixation time on PR antigen. Both insufficient fixation (72 hours) may lead to antigen loss. It is recommended that specimens be placed in 10% neutral buffered formalin as soon as possible after excision, with fixation time controlled at 24–48 hours. Misconception two: Adjusting signal solely by primary antibody concentration while neglecting DAB chromogenic time. Excessive chromogenic time produces nonspecific background; generally, the chromogenic process should be monitored under a microscope and the reaction terminated within 2–5 minutes. Misconception three: Failing to consider the applicability of antibodies with different clone numbers. For example, clone 1E2 has higher sensitivity for paraffin sections, while SP2 is more suitable for frozen sections; laboratories should choose based on actual needs. In summary, standardized operation and continuous optimization are the core of ensuring the detection quality of progesterone receptor antibody reagent (immunohistochemistry).